Regeneron Pharmaceuticals (REGN)

Investing Cash Flow

-$704.20M

TTM · Period ending: · USD

REGN logo

REGN Investing Cash Flow

Latest reported-$704.20M
REGN TTM Cash from Investing ($8.20M → -$704.20M)
High-resolution chart · PNG

REGN investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-704,200,000
-1,705,500,000
-629,100,000
-498,800,000
-670,300,000
-133,500,000
-2,468,100,000
-2,884,900,000
-2,806,800,000
-4,636,500,000
-3,185,100,000
-4,976,600,000
-4,288,000,000
-2,315,000,000
-3,784,600,000
-3,939,600,000
-6,570,700,000
-6,031,000,000
-5,384,700,000
-3,677,000,000
-2,014,000,000
-686,400,000
-70,600,000
25,700,000
594,500,000
-1,694,900,000
-2,027,800,000
-2,085,007,000
-2,164,715,000
-1,813,688,000
-1,463,000,000
-1,532,839,000
-1,605,015,000
-1,290,451,000
-1,005,182,000
-940,792,000
-987,761,000
-1,143,362,000
-1,046,904,000
-898,848,000
-776,166,000
-821,805,000
-907,601,000
-727,656,000
-567,553,000
-314,027,000
-420,777,000
-587,370,000
-678,754,000
-444,001,000
-355,455,000
-154,404,000
11,294,000
-244,524,000
-81,073,000
-206,084,000
-158,233,000
123,890,000
128,471,000
-191,395,000
-139,488,000
-277,828,000
-434,153,000
-99,549,000
-164,024,000
-96,294,000
146,000
103,987,000
180,235,000
-46,667,000
30,815,000
-17,393,000
-82,044,000
26,333,000
-85,723,000
-285,400,000
-217,063,000
-218,347,000
-155,105,000
33,412,000
12,749,000
86,199,000
115,494,000
97,758,000
38,566,000
-56,388,000
-4,583,000
-168,641,000
-97,624,000
-55,432,000
-63,843,000
127,583,000
100,060,000
90,230,000
-58,516,000
-119,658,000
-171,248,000
-169,199,000
-75,385,000
-63,911,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.